Ponatinib, High-Dose Chemo Combo Likely to Benefit High-risk BP-CML
AJMC,
Survival rates for patients with blast-phase chronic myeloid leukemia (BP-CML) are notoriously poor, necessitating effective…
Survival rates for patients with blast-phase chronic myeloid leukemia (BP-CML) are notoriously poor, necessitating effective…
(HealthDay)—Blast count seems to be the main prognostic count for patients with chronic myeloid leukemia (CML) presenting in an…
THURSDAY, Sept. 26, 2019 (HealthDay News) -- Blast count seems to be the main prognostic count for patients with chronic…
THURSDAY, Sept. 26, 2019 -- Blast count seems to be the main prognostic count for patients with chronic myeloid leukemia (CML…